Dermal Changes in the Lower Leg Skin of Patients With Venous Hypertension

The International Journal of Lower Extremity Wounds

Volumn 1, Issue 2, 2002, Pages 80-86

  Herrick, Sarah E ^a   Treharne, Linda J ^a   Degiorgio Miller, Alex M ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

fibrin; fibrosis; hemosiderin; lipodermatosclerosis; venous ulcers

Indexed keywords

EID: 84993725006     PISSN: 15347346     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534734602001002002     Document Type: Article

References (64)

1. Fowkes FG, Evans CJ, Lee AJ. Prevalence and risk factors of chronic venous insufficiency. Angiology 2001; 52(Suppl 1):S5-S15.
2. Kirsner RS, Pardes JB, Eaglstein WH, et al. The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol 1993; 28: 623-627.
3. Browse NL. Venous ulceration. Br Med J 1983; 286: 1920-1922.
4. Callam MJ, Ruckley CV, Harper DR, et al. Chronic ulceration of the leg: extent of the problem and provision of care. Br Med J 1985; 290: 1855-1856.
5. Baker SR, Stacey MC, Jopp-McKay AG, et al. Epidemiology of chronic venous ulcers. Br J Surg 1991; 78: 864-867.
6. Gross EA, Wood CR, Lazarus GS, et al. Venous leg ulcers: an analysis of underlying venous disease. Br J Dermatol 1993; 129: 270-274.
7. Miller WL. Chronic venous insufficiency. Curr Opin Cardiol 1995; 10: 543-548.
8. Peus D, Pittelkow MR. Resistance to activated protein C: a common anticoagulant deficiency in patients with venous leg ulceration. Br J Dermatol 1997; 7: 322-323.
9. Porter JM, Moneta GL. Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg 1995; 21: 635-645.
10. Browse NL. The pathogenesis of venous ulceration: a hypothesis. J Vasc Surg 1988; 7: 468-472.
11. Greenberg AS, Hasan A, Montalvo BM, et al. Acute lipodermatosclerosis is associated with venous insufficiency. J Am Acad Dermatol 1996; 35: 566-568.
12. Falanga V, Moosa HH, Nemeth AJ, et al. Dermal pericapillary fibrin in venous disease and venous ulceration. Arch Dermatol 1987; 123: 620-623.
13. Nemeth AJ, Eaglstein WH, Falanga V. Clinical parameters and transcutaneous oxygen measurements for the prognosis of venous ulcers. J Am Acad Dermatol 1989; 20: 186-190.
14. Schmeller W, Gaber Y. Surgical removal of ulcer and lipodermatosclerosis followed by split-skin grafting (shave therapy) yields good long-term results in “non-healing” venous leg ulcers. Acta Derm Venereol 2000; 80: 267-271.
15. Ahnlide I, Bjellerup M, Akesson H. Excision of lipodermatosclerotic tissue: an effective treatment for non-healing ulcers. Acta Derm Venereol 2000; 80: 28-30.
16. White WL, Wieselthier JS, Hitchcock MG. Panniculitis: recent developments and observations. Semin Cutan Med Surg 1996; 15: 278-299.
17. Fisher DA. Desideratum dermatologicum: eliminating lipodermatosclerosis; the term and its entities. Int J Dermatol 2000; 39: 490-492.
18. Hurietz C, Legache G, Desmons F. Ulceres de jambes et troubles trophiques d’origine veinuese (donnes tirées de l’etude d’un millier d’ulcereux hospitalisés). Rev Pract 1955; 5: 2703-2721.
19. Cantwell AR, Kelso DW, Rowe L. Hypodermitis sclero dermoformis and unusual acid-fast bacteria. Arch Dermatol 1979; 115: 449-452.
20. Alegre VA, Winkelmann RK, Aliaga A. Lipomembranous changes in chronic panniculitis. J Am Acad Dermatol 1988; 19: 39-46.
21. Jorizzo JL, White WL, Zanolli MD, et al. Sclerosing panniculitis. A clinicopathologic assessment. Arch Dermatol 1991; 127: 554-558.
22. Browse NL, Jarrett PE, Morland M, et al. Treatment of liposclerosis of the leg by fibrinolytic enhancement: a preliminary report. Br Med J 1977; 2: 434-435.
23. Naschitz JE, Boss JH, Misselevich I, et al. The fasciitispanniculitis syndromes. Clinical and pathologic features. Medicine 1996; 75: 6-16.
24. Burnand KG, Whimster I, Naidoo A, et al. Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. Br Med J 1982; 285: 1071-1072.
25. Leu AJ, Leu HJ, Franzeck UK, et al. Morphology of chronic venous insufficiency—light and electron microscopic examination. Vasa 1991; 20: 330-342.
26. Tronnier M, Schmeller W, Wolff HH. Morphological changes in lipodermatosclerosis and venous ulcers: light microscopy, immunohistochemistry and electron microscopy. Phlebology 1994; 9: 48-54.
27. Cesarone MR, De Sanctis MT, Incandela L, et al. Microvascular changes in venous hypertension due to varicose veins after standardized application of Essaven gel—a placebo-controlled, randomized study. Angiology 2001; 52(Suppl 3):S11-S16.
28. Fagrell B. Vital microscopy and the pathophysiology of deep venous insufficiency. Int Angiol 1995; 14(Suppl 1):18-22.
29. Wenner A, Leu HJ, Spycher M, et al. Ultrastructural changes of capillaries in chronic venous insufficiency. Exp Cell Biol 1980; 48: 1-14.
30. Pappas PJ, DeFouw DO, Venezio LM, et al. Morphometric assessment of the dermal microcirculation in patients with chronic venous insufficiency. J Vasc Surg 1997; 26: 784-795.
31. Bollinger A, Isenring G, Franzeck UK. Lymphatic microangiopathy: a complication of severe chronic venous incompetence (CVI). Lymphology 1982; 15: 60-65.
32. Browse NL, Burnand KG. The cause of venous ulceration. Lancet 1982; 2: 243-245.
33. Claudy AL, Mirshahi M, Soria C, et al. Detection of undegraded fibrin and tumor necrosis factor-alpha in venous ulcers. J Am Acad Dermatol 1991; 25: 623-627.
34. Herrick SE, Sloan P, McGurk M, et al. Sequential changes in the histological pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol 1992; 141: 1085-1095.
35. Stacey MC, Burnand KG, Bhogal BS, et al. Pericapillary fibrin de posits and skin hypoxia precede the changes of lipodermatosclerosis in limbs at increased risk of developing a venous ulcer. Cardiovasc Surg 2000; 8: 372-380.
36. Falanga V, Kirsner R, Katz MH, et al. Pericapillary fibrin cuffs in venous ulceration. Persistence with treatment and during ulcer healing. J Dermatol Surg Oncol 1992; 18: 409-414.
37. Scott HJ, Coleridge Smith PD, Scurr JH. Histological study of white blood cells and their association with lipodermatosclerosis and venous ulceration. Br J Surg 1991; 78: 210-211.
38. Wilkinson LS, Bunker C, Edwards JC, et al. Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg 1993; 17: 669-675.
39. Peschen M, Lahaye T, Hennig B, et al. Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency. Acta Derm Venereol 1999; 79: 27-32.
40. Coleridge Smith PD, Thomas P, Scurr JH, et al. Causes of venous ulceration: a new hypothesis. Br Med J 1988; 296: 1726-1727.
41. Naschitz JE, Yeshurun D, Schwartz H, et al. Pathogenesis of lipodermatosclerosis of venous disease: the lesson learned from eosinophilic fasciitis. Cardiovasc Surg 1993; 1: 524-529.
42. Brinckmann J, Acil Y, Tronnier M, et al. Altered x-ray diffraction pattern is accompanied by a change in the mode of cross-link formation in lipodermatosclerosis. J Invest Dermatol 1996; 107: 589-592.
43. Brinckmann J, Notbohm H, Tronnier M, et al. Overhydroxylation of lysyl residues is the initial step for altered collagen cross-links and fibril architecture in fibrotic skin. J Invest Dermatol 1999; 113: 617-621.
44. Peltonen J, Kahari L, Jaakkola S, et al. Evaluation of transforming growth factor beta and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. J Invest Dermatol 1990; 94: 365-371.
45. Lui B, Connolly NK. The pathogenesis of cutaneous fibrosis. Semin Cutan Med Surg 1998; 17: 3-11.
46. Higley HR, Ksander GA, Gerhardt CO, et al. Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration. Br J Dermatol 1995; 132: 79-85.
47. Herouy Y, May AE, Pornschlegel G, et al. Lipodermatosclerosis is characterised by elevated expression and activation of matrix metalloproteinases: implications for venous ulcer formation. J Invest Dermatol 1998; 111: 822-827.
48. Peschen M, Rogers AA, Chen WY, et al. Modulation of urokinase-type and tissue-type plasminogen activator occurs at an early stage of progressing stages of chronic venous insufficiency. Acta Derm Venereol 2000; 80: 162-166.
49. Saito S, Trovato MJ, You R, et al. Role of matrix metallo proteinases 1,2, and 9 and tissue inhibitor of matrix metallo proteinase-1 in chronic venous insufficiency. J Vasc Surg 2001; 34: 930-938.
50. Angel MF, Ramasastry SS, Swartz WM, et al. The causes of skin ulcerations associated with venous insufficiency: a unifying hypothesis. Plast Reconstr Surg 1987; 79: 289-297.
51. Phelps RG, Shoji T. Update on panniculitis. Mt Sinai J Med 2001; 68: 262-267.
52. Uitto J, Kouba D. Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases. J Dermatol Sci 2000; 24(Suppl 1):60-69.
53. Shoab SS, Scurr JH, Coleridge-Smith PD. Increased plasma vascular endothelial growth factor among patients with chronic venous disease. J Vasc Surg 1998; 28: 535-540.
54. Peschen M, Grenz H, Brand-Saberi B, et al. Increased expression of platelet-derived growth factor receptor alpha and beta and vascular growth factor in the skin of patients with chronic venous insufficiency. Arch Dermatol Res 1998; 290: 291-297.
55. Pappas PJ, You R, Rameshwar P, et al. Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-beta1 gene expression and protein production. J Vasc Surg 1999; 30: 1129-1145.
56. Falanga V, Eaglstein WH. The “trap” hypothesis of venous ulceration. Lancet 1993; 341: 1006-1008.
57. Ackerman Z, Seidenbaum M, Loewenthal E, et al. Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progression of the disease. Arch Dermatol 1988; 124: 1376-1378.
58. Ruiz GR, de la Torre P, Diaz T, et al. Sp family of transcription factors is involved in iron-induced collagen alpha1(I) gene expression. DNA Cell Biol 2000; 19: 167-178.
59. Pietrangelo A. Iron, friend or foe? “Freedom” makes the difference. J Hepatol 2000; 32: 862-864.
60. Leach RD, Browse NL. The clearance of 125I-labelled fibrin from the subcutaneous tissue of limbs with lipodermatosclerosis. Br J Surg 1986; 73: 465-468.
61. Jarrett PE, Burnand KG, Morland M, et al. Proceedings: fibrinolysis and fat necrosis. Br J Surg 1976; 63: 157.
62. Falanga V, Kruskal J, Franks JJ. Fibrin- and fibrinogen-related antigens in patients with venous disease and venous ulceration. Arch Dermatol 1991; 127: 75-78.
63. Margolis DJ, Kruithof EKO, Barnard M, et al. Fibrinolytic abnormalities in two different cutaneous manifestations of venous disease. J Am Acad Dermatol 1996; 34: 204-208.
64. Falanga V, Bontempo FA, Eaglstein WH. Protein C and protein S plasma levels in patients with lipodermatosclerosis and venous ulceration. Arch Dermatol 1990; 126: 1195-1197.